Why the study?
Does a low-dose chlorthalidone-based treatment regimen reduce stroke and cardiovascular events in elderly patients with isolated systolic hypertension?
Does a low-dose chlorthalidone-based treatment regimen reduce stroke and cardiovascular events in elderly patients with isolated systolic hypertension?
Treating isolated systolic hypertension in the elderly with a low-dose chlorthalidone-based regimen significantly reduces the risk of stroke, coronary heart disease, and major cardiovascular events.
No takes yet. Share an insight, caveat, or question.
May support low-dose chlorthalidone in elderly isolated systolic hypertension; leaves open confirmation by contemporary randomized trials.
A 1993 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: